Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Prostatic Neoplasms 56Lung Neoplasms 48Leukemia, Myeloid, Acute 44Breast Neoplasms 37Carcinoma, Non-Small-Cell Lung 36Myelodysplastic Syndromes 27Pancreatic Neoplasms 24Leukemia, Lymphocytic, Chronic, B-Cell 24Multiple Myeloma 23Colorectal Neoplasms 23Carcinoma, Renal Cell 22Neoplasm Metastasis 20Melanoma 19Glioblastoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Ovarian Neoplasms 17Lymphoma, Large B-Cell, Diffuse 17Brain Neoplasms 16Triple Negative Breast Neoplasms 14Squamous Cell Carcinoma of Head and Neck 12Carcinoma, Hepatocellular 12Lymphoma, Mantle-Cell 11Lymphoma, B-Cell 11Leukemia, Myelomonocytic, Chronic 11Fallopian Tube Neoplasms 11Rectal Neoplasms 10Myeloproliferative Disorders 10Lymphoma, Follicular 10Colonic Neoplasms 10Hematopoietic and Lymphatic System Neoplasm 9

Interventions

fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3Curcumin 3Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cyclosporine 2Busulfan 2Biopsy 2Antilymphocyte Serum 2pyroxamide 1piperine 1liposomal amphotericin B 1isatuximab 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Urination 1Topotecan 1Tissue Banks 1Therapeutics 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sucrose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Monoclonal Gammopathy of Undetermined Significance × Specimen Handling × Clear all
NCT03119883 2024-08-09

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Mayo Clinic

Phase NA Completed
35 enrolled
Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡